FANTOM Post Market Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1500 participants.
Also called NCT03587922
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,500 participants
- Sponsor
- Registry
-
NCT03587922
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria, Germany, Switzerland
- Registry status
- Unknown status
Technical summary
Registry record NCT03587922. Allocation not applicable; no masking; primary purpose treatment. Start 2018-05-01 (actual); primary completion 2025-05-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- FANTOM Post Market Clinical Trial
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Fantom
- Lead sponsor
- REVA Medical, Inc.
Record details
- Record id
cardio:ct-nct03587922- Content hash
9c6a9f06ab7c6afd46a47778c90fe37825fd54a695babc884778037631c8edec